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Abstract	  
The importance of glycosaminoglycans (GAGs) has been highlighted in many areas 
of research during recent years. Not only are they important in providing structure and 
support to our tissues but they also function as interaction partners in the extracellular 
matrix and at the cell membrane. The chemical structure and most notably the high 
negative charge of GAGs give them unique and interesting features, but also makes 
studying GAG-related interactions challenging. Biofunctional immobilization of 
GAGs to surfaces opens up for the use of many surface sensitive techniques that 
could provide detailed information about how these molecules regulate tissue growth 
and maintenance as well as the development of diseases. 
 
In this thesis, different methods for immobilizing GAGs to surfaces have been 
investigated with the aim of studying GAG-related interactions. Two surface 
modifications have been used: supported lipid bilayers and self-assembled 
monolayers, both having suitable qualities for molecular immobilization and 
interaction studies. Immobilization of the GAGs hyaluronic acid and chondroitin 
sulfate was achieved using different methods. Immobilization was followed in real-
time using quartz crystal microbalance with dissipation monitoring and surface 
plasmon resonance. Several GAG-interacting proteins were studied: e.g. bone 
morphogenetic protein-2, aggrecan, and virus glycoproteins. 
 
Studying the interactions revealed interesting aspects of the interaction in itself, as 
well as highlighted important aspects regarding the surface immobilization of the 
GAGs. The interactions are highly dependent on the surface orientation of the GAGs 
and pros and cons with side-on versus end-on immobilization of GAGs are discussed 
in the thesis. The immobilizing technique, especially if functional groups are 
introduced on the GAG, also influences how the GAG is perceived by a secondary 
protein. 
 
Potential applications of the GAG platforms are described; studying initial attachment 
of chondrocytes towards better cartilage implants and aggregation of platelets at a 
surface interface. 
 
Keywords: glycosaminoglycans, extracellular matrix, molecular immobilization, 
interaction studies, QCM-D 
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1 Introduction	  
The human body is a remarkable and complex creation where everything from our 
breathing to the shape of our nose is regulated by interactions of molecules. The 
movement of my fingers when writing this text is brought about by a flux of ions 
through the lipid membrane of nerve cells, causing energy conversion and 
conformational changes in motor proteins resulting in muscular contraction. Except 
from realizing the mere beauty in these molecular interplays, such knowledge is 
necessary for understanding diseases, recognizing them at an early stage (diagnostics) 
and finding ways to treat them (drug discovery/therapeutics). 
 
The regulation of an organism’s function can be divided into three major areas: 
genomics, proteomics and glycomics.1 The first two concern the study of how our 
genes are regulated, translated into proteins, and the structure and function of these 
proteins. Glycomics, the study of sugars/carbohydrates, is the least studied discipline 
among the three, as a consequence of complicated synthesis and varying structure of 
GAGs. Despite this, they are by no means unimportant but have a multitude of 
functions in our bodies. Glycosaminoglycans (GAGs) are part of both the 
extracellular matrix and the cell membrane and have diverse functions like building 
up tissue structures, cell signaling and disease progression.2-5 
 
A variety of biosensor methods have been developed to study biomolecular 
interactions, where the biological event is transformed to a measurable signal.6 
Depending on the method used, the molecules of interests might need to be labeled 
with e.g. a fluorescent or radioactive tag. Valuable information about if an interaction 
occurs or not can be gained, and where in e.g. a tissue section it takes place. However, 
to study the interaction more in detail and to get information about e.g. kinetics, a 
label might be disturbing. For this reason, label-free techniques have been developed.7 
Many of these techniques are surface-based in order to increase control and sensitivity. 
To confine the biomolecular interaction to a surface, immobilization of one of the 
reacting molecules is necessary. Often, and in this work, the immobilized molecule is 
called the ligand and the interacting molecule the analyte. The surface-based 
techniques can allow rapid and high throughput characterization, where the 
interaction between different analytes and a single ligand can be probed, either 
simultaneously or sequentially by regenerating the surface.8 This is very useful for 
investigating new and unknown interactions, but also for elucidating a single 
interaction when concentration, pH, and salt concentration need to be varied. 
 
Appropriate immobilization of GAGs will allow studies of GAG-related interactions 
and how these molecules affect tissue growth and maintenance and the development 
of diseases. This knowledge, together with the immobilization protocol could lead to 
the development of new diagnostic tools, tissue-supporting implants, and cell 
substrates for tissue engineering. 
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1.1 Aim	  
The aim of my work is to investigate the function of GAGs, with a focus on GAGs 
found in bone and cartilage tissues. Thus, it is of interest to study how GAGs interact 
with other biomolecules crucial for tissue development and maintenance, like ECM 
constituents, growth factors, pathogens, cell membrane proteins or whole cells. To be 
able to study this with surface sensitive techniques, the GAGs need to be immobilized 
to a surface. The work presented here is hence aiming at creating platforms for 
suitable immobilization of GAGs. The usefulness of the platforms was evaluated by 
probing interactions with various proteins. 
 
These results are part of FIND & BIND, an EU project aiming at investigating the 
role of carbohydrates in bone and cartilage tissues.1  
  
                                                
1  The research leading to these results has received funding from the European Union Seventh Framework 
Programme (FP7/2007– 2013) under Grant Agreement No. NMP4-SL2009-229292 (“Find & Bind”). 
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2 Glycosaminoglycans	  
2.1 Structure	  and	  in-­‐vivo	  synthesis	  
Glycosaminoglycans (GAGs) are long, unbranched polysaccharide chains consisting 
of repeated units of disaccharides (Figure 1).9 The monomers consist of a 6-carbon 
ring with or without an attached amine group. A glycosidic bond links the monomers 
together. Two examples of GAGs are shown in Figure 2, hyaluronic acid (HA) and 
chondroitin sulfate (CS) consisting of the monosaccharides glucuronic acid and N-
acetylgalactosamine. In CS, either of these can be sulfated.10 
 
 
Figure 1. Part of the glycosaminoglycan family tree. 
 
Figure 2. Molecular structure of the repeating disaccharide unit of a) hyaluronic acid (HA) and 
b) chondroitin sulfate (CS) type A. 
The GAG chain has a structural direction, having a reducing and a non-reducing end. 
The monomer at the reducing end is in equilibrium between an open form and a 
closed form (Figure 15). The open form presents an aldehyde that can react with a 
hydroxyl group on another monomer to elongate the chain. 
 
carbohydrates
monosaccharides
(glucose)
disaccharides
(sucrose)
oligosaccharides
polysaccharides
branched
(glycogen)
linear glycosaminoglycans
(hyaluronic acid,
chondroitin sufate,
dermatan sulfate,
keratan sulfate,
heparin,
heparan sulfate)
a) b)
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Most GAGs are attached via their reducing end to a protein core, forming a 
proteoglycan. Proteoglycans can either be attached to the cell membrane or free in the 
extracellular matrix (ECM) as seen in Figure 3.3 They are synthesized and secreted 
by most vertebrate cells. The glycosylation, i.e. the attachment of GAGs to the core 
protein, begins in the endoplasmic reticulum and continues on its way through the 
Golgi apparatus.5 Here, the GAGs are also sulfated by sulfotransferases.5,11 The 
resulting pattern for this sulfation is not fixed or well understood. CS is divided into 
different types depending on where the sulfate groups are placed; A (chondroitin-4-
sulfate), C (chondroitin-6-sulfate), D (chondroitin-2,6-sulfate) and E (chondroitin-4,6-
sulfate). Type B used to be a CS type but is now called dermatan sulfate.12 Hyaluronic 
acid (HA) is an exception from other GAGs, as it is neither attached to a protein core, 
nor sulfated.13 HA is synthesized on the inner side of the plasma membrane by 
hyaluronan synthase and is then transported out to the ECM where it interacts with 
proteins and proteoglycans (Figure 3a).   
 
 
Figure 3. Examples of GAGs in the ECM and at the cell membrane. a) The proteoglycan 
aggrecan, consisting of the GAGs chondroitin sulfate (CS) and keratin sulfate (KS) bind to the 
GAG hyaluronic acid (HA) together with a link protein (LP). b) The proteoglycan syndecan at 
the cell membrane consisting of CS and heparan sulfate (HS).  
2.2 In-­‐vivo	  function	  
One important function of GAGs in the ECM is their mechanical properties, giving 
support to the tissue5 as well as lubricating joints.14 They are also involved in many 
interactions mediating cell growth and proliferation,3,4 stabilizing growth factors,15 
viral infection,2 and thrombosis regulation16,17. The many possible sites for sulfation, 
discussed above, make GAGs very diverse in structure and a “sulfation code” has 
been suggested as a regulator of much of their function.3,5 For example, the ratio 
between CS-A and CS-C is fine-tuned during the different stages in embryonic 
development and also vary with age.4 
 
The involvement of GAGs in many, biologically vital mechanisms and the possibility 
of chemical alteration and functionalization make them an interesting focus for 
biosensor research. By immobilizing GAGs to surfaces, many of these interactions 
can be studied in detail. Investigating their interactions with growth factors can be 
useful in implant and scaffold design. Cellular attachment and signaling can be 
studied as GAGs function as signaling molecules. Important molecular aspects of 
viral infection and blood coagulation can also be studied. 
a) b)
Aggrecan
HA
LP
CS
KS
CS
HS
Syndecan
 5 
3 Immobilizing	  biomolecules	  to	  surfaces	  
Finding a suitable way of immobilizing GAG derivatives to surfaces has been a major 
part of this project so far. General issues will be discussed along with a few examples 
of how immobilization could be made, both concerning modifications of the molecule 
and the surface. Finally, GAG immobilization in particular will be discussed.  
 
Surface-based biosensor techniques can give deep insight into a specific interaction 
but for that to occur, care must be taken to preserve the molecule in its native form as 
much as possible.8 The introduction of specific functional groups onto the molecule 
under study might be necessary but should be performed in such a way that the 
interaction of interest is hindered as little as possible. When studying the function of 
an enzyme for example, the enzyme should not be immobilized at its binding pocket. 
Analyte binding to the background should be minimized in order to to get as much 
information as possible about the analyte-ligand interaction. Consideration of the 
above comes down to choosing a good immobilizing technique and a good surface. 
The definition of “good” in this case depends on the answer to several questions: 
 
 
What surface sensitive technique will 
be use? 
à  
 
A specific technique usually requires 
specific surfaces (e.g. gold or glass) 
and the immobilizing system needs to 
be compatible with this surface. 
 
How are the molecules expected to 
interact? 
à  
 
Estimating how the interaction will 
take place gives clues on appropriate 
immobilization with respect to e.g. 
orientation and surface density. 
 
What variants of the ligand are 
available? 
à Molecules functionalized in a specific 
way are not always commercially 
available and can be costly or 
cumbersome to synthesize.  
 
Answers the above questions, and issues relating to this, will determine the 
immobilization method used. 
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3.1 Immobilization	  techniques	  
When studying the interaction between a ligand and an analyte, the stability of the 
surface-ligand binding needs to be trusted. By choosing chemically active groups on 
the surface and on the ligand, covalent bonds or strong non-covalent bonds between 
the two can be formed. The chosen technique should be as general as possible, to 
allow for the use of different ligands without changing the protocol. The techniques 
mentioned below are a few examples of commonly used immobilizing methods.  
3.1.1 Amide	  bond	  formation	  using	  EDC/NHS	  
A common way of creating a covalent bond is by letting a carboxyl group react with a 
primary amine creating an amide bond, the same bond that links amino acids together 
in a protein.18 In vivo, this reaction is brought about by the action of many enzymes 
and other molecules. In vitro, the use of coupling reagents is necessary. For example, 
the carboxyl group is converted to an ester by the use of N-(3-dimethylaminopropyl)-
N′-ethylcarbodiimide hydrochloride (EDC). The ester can then react with the amine to 
form the amide bond. In order to increase the yield of this interaction, N-
hydroxysuccinimide (NHS) is usually used together with EDC (Figure 4). It reacts 
with the EDC-ester, protects it from hydrolysis and makes a better leaving group for 
the subsequent reaction. Usually, carboxyl groups on the surface are activated and a 
ligand displaying primary amines is added. To avoid that the analyte also reacts with 
the activated surface, deactivation is normally performed using ethanolamine.19 
 
 
Figure 4. An amide bond created by reacting a carboxyl group on a surface and a primary 
amine on a ligand, with the use of EDC and NHS as coupling reagents. 
3.1.2 Biotin-­‐avidin	  coupling	  
The strong interaction (KD ≈ 10-15 M) between biotin and avidin has been used for 
decades for immobilizing biomolecules to surfaces (Figure 8).20 Bacterially derived 
streptavidin (SA) can be used instead of avidin, also exhibiting a strong binding to 
biotin (KD ≈ 10-13 M). It is non-glycosylated and has a pI closer to neutral pH (pI ≈ 5-
6) and therefore shows lower non-specific interactions. Neutravidin (pI = 6.3), a de-
glycosylated variant of avidin, is also sometimes used.21 All of the three variants have 
four binding sites for biotin. The biotin-avidin interaction has been used for a number 
of diffrent systems and is, except for its strong binding, appreciated for its 
compatibility with different conditions in terms of pH, temperature, and denaturation. 
EDC NHS
NH2
ligand
NH
ligandC
C2H5 C5H12NC
C2H5 C5H12N
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3.1.3 Layer-­‐by-­‐layer	  assemblies	  
Building multilayered structures between two species of opposite charge is an easy 
way to build large molecular structures on surfaces.22 It requires no special equipment 
and has few limitations when it comes to substrates. By starting with a negatively 
charged surface, a polycation can be electrostatically adsorbed to the surface under 
the right buffer conditions. The surface becomes positively charged and a polyanion 
can be adsorbed in the same way (Figure 5). This straightforward fabrication makes it 
versatile in use for cell substrates and biomaterials. Even though the making of these 
layers is simple, the control and tuning of layer characteristics (final charge, 
roughness, stability) can be complicated. 
 
 
Figure 5. Formation of a polyelectrolyte multilayer via layer-by-layer assembly.  
3.2 Surface	  modifications	  for	  immobilization	  
3.2.1 Supported	  Lipid	  Bilayers	  
A lipid molecules has a hydrophilic (water-loving) head and a hydrophobic (water-
hating) tail (Figure 6a). These characteristics make lipids self assemble when put in a 
solvent. In a water solvent, a spherical bilayer structure, a vesicle, will form where the 
heads are directed outwards and the tails into the bilayer (Figure 6b). This self-
assembling is also the basis of the membrane that surrounds all the cells in our body. 
It consists of many types of lipids and also functional proteins and carbohydrates. Via 
the membrane, the cell communicates with surrounding cells and with the ECM. 
 
 
Figure 6. a) Schematic and chemical structure of a membrane lipid, here exemplified with 
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine. b) Lipids self-assemble into a 
vesicle in a water solution. 
1) polycation
2) wash
1) polyanion
2) wash
hydrophilic headhydrophobic tail
a) b)
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Supported lipid bilayers (SLBs) are model mimics of the cell membrane and can be 
formed on solid supports, e.g. silica, by different methods, e.g. the vesicle-rupture 
technique shown in Figure 7.23 Lipids in a vesicle are fluid, and the fluidity is kept in 
the SLB by a thin layer of water between the support and the lipids.24 SLBs combined 
with surface-based sensor techniques are extensively used to study processes taking 
place at or near the cell membrane. Due to the mobility of the lipids, and the fact that 
SLBs are excellent in minimizing non-specific interactions, they are often modified to 
extend their usability for studying interactions involving e.g. cells,25,26 proteins27 and 
DNA.25,28  
 
 
Figure 7. Lipid vesicles adsorbing on a silica surface. When a critical coverage is reached, 
the vesicles start to rupture, forming a supported lipid bilayer. 
3.2.2 Self-­‐Assembled	  Monolayers	  	  
Another spontaneous process resulting in an ordered structure is the self-assembled 
monolayer (SAM), referring to a single layer of molecules on a solid support,29 the 
most used system being alkane thiols adsorbing on a gold surface (Figure 8). The 
semi-covalent bond between gold and sulfur in the thiol creates a close-packed, 
oriented system where a functional molecule can be added to the other end of the 
alkane chain. This functional group (e.g. carboxyl, amine or biotin) can be used to 
specifically bind other biomolecules30 or cells31. It is preferred that binding only 
occurs to these functional groups, and the use of poly(ethylene) glycol (PEG) or 
oligo(ethylene) glycol (OEG) chains as part of the alkanes have been found to 
minimize unspecific binding of proteins.32  
 
 
Figure 8. Formation of a self-assembled monolayer. A gold surface is incubated in a thiol 
solution for >12h. The strong orientation of the thiols allows for functionalization of the other 
end, here exemplified with biotin (red dots) able to bind streptavidin in the next step.   
S SSSS SSSS S SS SSSS SSS SSSS SSSS SS SSSS SS S
S
S
S
S
S
S
S
S
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3.3 Immobilization	  of	  glycosaminoglycans	  
Immobilization of GAGs and other carbohydrates to surfaces can be done either 
directly by pinning down the GAG itself, or indirectly by immobilizing the molecule 
which it is part of, e.g. a proteoglycan or a glycolipid.33 The indirect method allows 
for the use of the numerous immobilization strategies developed for proteins but with 
this method the interaction with the total GAG complex is studied. The direct method 
focus the studied interaction to the GAG itself, requiring immobilization of a non-
functionalized GAG (e.g using the layer-by-layer method, section 3.1.3) or a 
functionalized variant.  
 
Functionalization of the GAG allows for directed immobilization to a surface using 
suitable chemistry for that surface, e.g. amines (section 3.1.1),34 biotin (section 
3.1.2),35,36 or thiols.37 It also gives the opportunity to tune the amount of binding sites 
on the molecules. Functionalization of GAGs is usually done to the carboxyl groups 
or the hydroxyl groups along the chain. Another possibility is to use the reducing end 
of the GAG (section 2.1) that in its open form presents an aldehyde group.38 Examples 
of functionalization can be seen in Figure 9. 
 
 
Figure 9. Top: molecular structure of CS. The reducing end is in equilibrium between the 
closed and open form. Bottom: functionalization of CS an a) side-on and b) end-on 
configuration. 
EDC
i) R-NH2
ii) NaCNBH3
a)
n
n
n Rn
R
  R-NH2
b)
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4 Glycosaminoglycan	  interactions	  
The interest for studying GAG interactions is increasing. This section is by no means 
a complete overview of the findings regarding this but is highlighting aspects about 
these complicated interactions. Examples of GAG-related interactions will be 
presented (4.2 & 0) and emphasized again in the result section. 
4.1 General	  aspects	  
Much of GAG function is governed by interactions with other molecules, usually 
different kinds of proteins. The nature of proteoglycans encourages the formation of 
larger supramolecular assemblies where both the protein core and the GAG chains are 
available for interaction. As an example, the core protein of aggrecan forms 
aggregates by binding to HA together with a link protein (Figure 3a).39,40 The GAG 
chains in aggrecan are in turn thought to bridge between collagen molecules further 
extending this supramolecular assembly.41 Finding interacting sequences in the GAGs 
primary structure is not as straightforward as for proteins, since GAG synthesis is 
not coded in a template like DNA and is therefore not as defined. However, just as for 
proteins, GAGs have secondary structures, as they can adopt a helical structure 
stabilized by hydrogen bonds.9,42 The helix formation can create hydrophobic patches 
along the otherwise hydrophilic molecule, likely favoring binding both to other GAGs 
and to proteins. Hence there is likely also a tertiary structure, where multiple GAG 
chains can align in a β-sheet structure.43 
4.1.1 Multivalency	  	  
The affinity for a binding between a GAG and a protein at a single interaction site is 
usually very low and the overall strength of GAG-protein interactions, the avidity, is 
due to multivalency.44,45 Multivalency is important for strength and specificity in 
many biological interactions and can involve GAGs binding multiple proteins as well 
as proteins having multiple binding sites for GAGs (Figure 10). Multivalency 
complicates evaluation of an interaction, especially when the nature of the interaction 
is not fully known.46 If the analyte binds in a multivalent manner, the response will be 
highly dependent on the density of ligands on the surface. In these cases it is better to 
let the multivalent molecule be the immobilized ligand and usually when studying 
GAG-protein interactions, the GAG is immobilized.33 The multivalent nature of GAG 
interactions also suggests their involvement in cross-linked structures.47 
 
Figure 10. a) monovalent binding, b) a multivalent analyte binds to ligands on the surface, c) 
a multivalent ligand binds to analyte molecules from the solution, d) a multivalent analyte 
binds to a multivalent ligand with the possibility of crosslinking. 
a) b) c) d)
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4.1.2 Specificity	  
The specificity of GAG-protein interactions is a complex question and debated in 
several review articles.9,48 First, the distinction between specific and non-specific 
interactions is not clear cut, especially when polyelectrolytes are involved.49 The 
specificity of GAG-protein interactions likely comes from hydrogen bonds, e.g. 
between the amino acid tyrosine and hydroxyl groups on the GAG, and from 
hydrophobic interactions.10 Just as for protein-protein interactions, geometrical 
arrangements of the interacting partners are thought to play an important role. Today 
only a few specific GAG-protein interactions are known and most of them concern 
the heparin sulfates. However, as more knowledge is gained on the sulfation patterns 
of GAGs and the way they govern protein interactions, specific interaction sequences 
are likely to be found in this. 
4.1.3 Quantifying	  binding	  characteristics	  
For quantitative analysis of an interaction, binding constants are usually established.  
In simple terms, a biomolecular interaction can be explained by eq. 1: 
 ! + !    !!↔!!   !"                                                                                                                                                                                                                                                          (1) 
 
where A and B are the two interacting partners and ka and kd are the association and 
dissociation rate constants, respectively. The equilibrium association and dissociation 
constant are defined as: 
 !! = !"! ! ,      !! = 1!! = ! !!"                                                                                                                                                                                2  
  
KD is more often used in interaction analysis, where a low value indicates a strong 
interaction. If the interaction takes place at a surface, the binding of analyte A to 
ligand B can be related to the Langmuir adsorption isotherm and the rate of change in 
surface coverage can be explained by: 
 !"!" = !! ! !!"# − ! − !!!                                                                                                                                                                                            (3) 
 
where the first part accounts for association to the surface and the second part for 
dissociation from the surface. θ is the surface coverage at time t and θmax is the 
maximum surface coverage. At equilibrium, the rate of change is zero and solving for 
θ gives: 
 ! = ! !!"#!! + !                                                                                                                                                                                                                                                         (4) 
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where kd/ka = KD. If KD equals [A] then according to eq. 4, θ = θmax/2. In other words, 
KD equals the bulk concentration at which half of the receptor on the surface are 
occupied. 
 
Fitting measurement data to eq. 4 is only reasonable if the Langmuir model holds.50 
The model comes with many prerequisites: pure samples, homogenous surface with 
all sites equal and non-cooperativity. Care must be taken as to not draw conclusions 
based on poorly fitting data. The Langmuir models can obviously be extended to 
include various other parameters. However, even if complicated models often provide 
a better fit, they do not necessarily give a more true explanation of the data. 
4.2 GAG	  interactions	  with	  ECM	  proteins	  
Today, hundreds of proteins are known to interact with GAGs although the nature and 
significance of these interactions are not always known.45 Perhaps the most well-
known, studied and used interaction is heparin acting as an anticoagulant by binding 
and activating anti-thrombin III.51 The GAG-interacting partner could be of structural 
importance, like collagen, or other polysaccharides and proteoglycans, enzymes, 
growth factors or chemokines.9,52  
Collagen in its many forms is the most abundant protein in the ECM and known to 
form aggregates with the other main ECM-constituents; proteoglycans and HA.41,53 
Both the protein core and the extending GAG chain on the proteoglycans participate 
in this interaction. The sulfation patterns on the GAG chains matters for the 
interaction, where an over-sulfated variant of CS, CS-E, has a higher binding to most 
collagen proteins. Ionic interactions are likely dominating since there is a strong 
dependence on ionic strength and pH.41 The nature of collagen-GAG interaction is 
difficult to investigate due to the different types and forms of collagen and the fact 
that the whole proteoglycan takes part in the interaction. However, the supramolecular 
structures built up by collagen are likely to be important for tissue structure and are 
often used in tissue engineering research. It was recently shown that a complex of 
type I collagen and CS, with and without the growth factor BMP-4 was beneficial for 
increased bone growth.54 
 
Aggrecan is another important constituent in cartilage ECM. It forms supramolecular 
assemblies by binding through the N-terminal of the protein core to HA chains 
together with a link protein (Figure 3a).40 HA also has a cell surface receptor, CD44, 
that binds HA along with aggrecan aggregates, thus stabilizing the ECM.55 The 
stability of HA-aggrecan assemblies is pH dependent and they are therefore thought to 
be involved in the tissue response to inflammation.39 This is also supported by the fact 
that HA binds an inflammation-response protein, TSG-6.56 Elucidation of the 
interaction between HA and aggrecan could give valuable insight in how cartilage 
degenerative diseases like osteoarthritis initiate and progress. 
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Enzymes are not only involved in GAG synthesis within the cell but also regulate 
GAG levels in the ECM. More or less specific enzymes act on the different GAGs; 
heparinase I and II, chondroitinase ABC, hyaluronane lyases, and hyaluronidase, 
decreasing the amount of GAGs and hence regulating their functions.9,57 Some cancer 
cells secrete GAG degrading enzymes, indicating that proteoglycans are involved in 
cancer metastasis. As mentioned previously, the sulfation patterns of GAGs change as 
the tissue develops and ages, a reaction also governed by sulfatases.58 
 
GAGs are situated both in the ECM and at the cell membrane and therefore have an 
ideal placement to be involved in extracellular signaling events. Growth factors are 
substances that regulate cell behavior and participate in cell-cell communication. The 
crucial role of growth factors in tissue development has led to an increased use in 
research and in clinic. For example the growth factor bone morphogenetic protein-2, 
BMP-2, is used to enhance bone growth.54,59,60 The half-life of growth factors is short, 
causing problems when administering it to the tissue in solution.61,62 In vivo this is 
solved by interactions with ECM molecules that protect the growth factors from 
degradation by proteases. This led to the idea of combining growth factors with GAGs 
for administration, which proved to stabilize them and retain their functionality.15 The 
positively charged growth factors easily attach to the negatively charged GAGs but 
the exact mechanism behind this interaction is not fully understood. It has been 
suggested that heparin-like GAGs interacts specifically with the basic N-terminal of 
BMP-2 and that each BMP-2 molecule, being a dimer, could bind two GAG 
chains.63,64 Interaction between BMP-2 and the non-sulfated HA has also been seen, 
hypothesized as arising from ionic interactions.62 The 3D structure of BMP-2 has 
been shown65 and 3D rapid prototyping suggests that the homo dimer presents a 
helical binding pocket suitable for left handed helixes,66 a conformation that GAGs 
are energetically likely to adopt.67 
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4.3 Interactions	  with	  viruses	  
Viruses are small pathogens that lack the ability of replicating. Their only way of 
multiplying is by hijacking a host cells replication machinery. Host cell infection 
starts with attachment to the surface of the cell and later penetration into it. The viral 
genome is then replicated within the cell. Virus proteins are synthesised and new virus 
particles can be created. After exiting the host cell, the new virus particles, virons, can 
infect other cells nearby. The virion is protected by a capsid, a protein core, and some 
virus, e.g. the herpes simplex virus (HSV), also have a lipid membrane as an outside 
cover, called the envelope.2 The envelope also contains many kinds of glycoproteins, 
which mediate both attachment and entry into the host cell. Since much of the host 
cell membrane displays different kinds of GAGs, it is perhaps not surprising that 
many viruses use these molecules to attach and direct their entry into the cell. Most 
HSV-attachment studies involve the binding of envelope glycoproteins to HS68 but 
binding has also been shown to CS69. The GAG-binding region on the glycoproteins 
is thought to consist of clusters of positively charged amino acid and basic residues. 
These regions can bind electrostatically to negatively charged GAGs but there is 
likely also more specific hydrogen bonding involved. The spacing of sulfate groups 
along the GAG is also thought to be important.68 Understanding the mechanism 
behind attachment and entry of viruses could help in designing more general and 
efficient vaccines and anti-viral drugs. 
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5 Experimental	  techniques	  
In this section, techniques applied for studying formation and characterization of 
GAG platforms in the present work will be described. 
5.1 Quartz	  Crystal	  Microbalance	  with	  Dissipation	  Monitoring	  
Quartz Crystal Microbalance with Dissipation Monitoring (QCM-D) is a surface-
based mass sensitive technique often used in biosensing.70 The basis of QCM-D lies 
in the quartz, a piezoelectric material developing a charge potential when mechanical 
stress is applied.71 Conversely, movement of the crystal can be brought about if a 
potential is applied across a quartz crystal disc, which in QCM-D is achieved by 
putting gold electrodes on both sides of the crystal sensor. By applying an alternating 
potential, the QCM-D sensor will deform repeatedly in a so-called shear-thickness 
mode (Figure 11).72 
 
 
Figure 11. When an alternating potential is applied to an AT-cut quartz crystal (like a QCM-D 
sensor), the crystal deforms in a shear-thickness motion. 
The applied potential will cause the crystal to oscillate at a certain frequency. The 
most stable oscillation occurs at the crystals resonance frequencies, where all the 
added energy is converted into motion. The resonance frequency for a QCM-D crystal 
occurs at 5 MHz (fundamental frequency) and odd multiples of this.70 During a 
measurement, all resonance frequencies are measured simultaneously. The sensitivity 
is highest in the centre of the crystal and the sensing depth is decreased for higher 
overtone numbers. When something adsorbs on the sensor surface, it is monitored as a 
decrease in the oscillating frequency (Figure 12). 
 
 
Figure 12. Schematic QCM-D graph showing frequency and dissipationi responses obtained 
during material adsorption. As material adsorbs, frequency (black) decreases and dissipation 
(light grey) increases. If the adsorbed layer is loose the dissipation is high (solid), if it is dense 
the dissipation is low (dashed). 
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In QCM-D, the applied potential is continuously switched on and off, which 
distinguishes this technique from other QCM techniques. When switched off, the 
oscillation decays and it is possible to measure the damping of the system, resulting in 
a parameter called dissipation, expressed in eq. 5:72 
 ! = 12!×!!"##"$%&'!!!"#$%&                                                                                                                                                                                                                             (5) 
 
For thin, rigid layers (small D) the mass adsorbed on the sensor can be described by 
the Sauerbrey equation: 
 ∆! = −!∆!!!                                                                                                                                                                                                                                                       (6) 
 
were Δm is the change in mass, C is a crystal specific constant (17.7 ng/(cm2⋅Hz)), n 
is the overtone number and Δfn the frequency change measured for that overtone.73,74 
The Sauerbrey equation is the simplest and perhaps the most used way of estimating 
mass. Since this mass sensor is based on movement of the sensor, it will detect 
anything that is acoustically coupled to the sensor. That is not only the adsorbed film 
but also solvent that moves along with the film will be sensed. To estimate the mass 
of a film having high water content, the Sauerbrey equation cannot be used. Instead, a 
model taking the viscoelastic properties of the layer into account is suitable, e.g. by 
the use of Voigt elements.75 The fact that associated water is also measured makes it 
possible to measure highly hydrated systems that can be difficult to sense with e.g. 
optical techniques.76 
Here, frequency data were always normalized with regard to the overtone number. 
5.2 Surface	  Plasmon	  Resonance	  
Surface plasmon resonance is a phenomenon used for detecting adsorbed mass on a 
surface. A surface plasmon is a charge-density wave that can exist at the interface 
between two media where the dielectric constants are of opposite sign, e.g. between a 
free-electron metal and a dielectric.77 The plasmon can be excited by interaction with 
another energy wave in resonance, i.e. a light wave. The plasmon, and hence the 
resonance condition, is highly sensitive to changes at this interface, e.g. adsorption of 
a material with optical properties different from the bulk. 
 
An SPR instrument is usually built according to the Kretschmann configuration 
(Figure 13).78 
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Figure 13. The Kretschmann configuration of an SPR setup. kx and ksp are the wave vectors 
for the horizontal component of the light and the plasmon and εa, εm and εg are the dielectric 
constants for the medium, the metal and the glass prism. 
A glass prism is coated with a thin metal film, usually gold.77 Light is applied through 
the prism such that it hits the interface at an angle above the critical angle, θ > θc 
where total internal reflection occurs. Under these conditions no light is transmitted 
through the gold film but an electrical field wave is created, having an intensity that 
decays exponentially from the surface (the evanescent field).  
 
The wave vectors for the plasmon, ksp, and for the parallel component of the incident 
light, kx are given by: 
 !!" = !! !!(!)!!!! ! + !!   = !! ≫ !! = !! !! = !!   !!                                                                                      (7) 
 !! = !! !!!"#$                                                                                                                                                                                                                                              (8) 
 
where ω is the angular frequency, c is the speed of light, εa, εm and εg are the 
dielectric constants for the ambient medium, the metal, and the glass prism, na is the 
refractive index of the ambient medium and θ is the incident angle of the light.79 For 
the plasmon and the light to be in resonance, kx and ksp need to be equal and energy is 
then transferred from the light to the plasmon, causing a dip in the intensity of the 
refracted light sensed by a detector.79,80 As molecules attach to the sensor surface, the 
plasmon will shift due to changes in the refractive index, na. According to ksp = kx, the 
angle of incidence, θ, then needs to change. By scanning the incident angle until the 
resonance conditions are found, the new refractive index can be calculated.77 
 
When communicating SPR data, the displacement of the resonance angle is 
sometimes reported. For the commonly used BIAcore instrument, values are often 
given in resonance units (RU). The RU values depend on the change in refractive 
index, Δn, which in turn is related to the surface concentration of the adsorbed 
biomolecule. Mass, or surface coverage ng/cm2, can be estimated using eq. 9:28 
Θ
evanescent field
ksp
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kx
glass prism
metal film
εg
εm
εa
detector
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where CSPR is a constant accounting for the decay length of the evanescent field, the 
sensitivity of the instrument and the refractive index increment for the adsorbed 
substance, dn/dC, and β a factor compensating for the distance from the sensing 
surface. To calculate the CSPR values for immobilized GAG layers, it was assumed 
that CSPR = 0.066 ng/cm2 for a protein with dn/dC = 0.18 ml/g adsorbing on a flat gold 
surface and that CSPR varies linearly with dn/dC.28 For glycosaminoglycans like HA 
and CS, many different values for dn/dC can be found in the literature, ranging from 
0.155-0.176 for HA81 and 0.129-0.17 for CS.82-84 This is likely due to measurements 
being made in different buffers and at different wavelengths. In this work, mean 
values of these literature values have been used to calculate usable CSPR values. sHA 
is assumed to have the same dn/dC as CS as it is also highly sulfated. 
 
Water associated with the sensed molecules is not measured with SPR, since only the 
difference from the surrounding media (containing water) is sensed.  By subtracting 
modelled SPR masses from QCM-D masses (which include associated water), the 
water content of a layer of biomolecules can be estimated.28,85 Measurements with 
SPR are also often used to estimate specificity, affinity and kinetics for a given 
interaction. 
5.3 Fluorescent	  Recovery	  After	  Photobleaching	  
Fluorescent recovery after photobleaching, (FRAP) is a convenient method to monitor 
the lateral diffusivity of fluorescently labelled molecules.86 This can be useful for 
different kinds of systems, but a typical application is to monitor the mobility of lipids 
in a lipid bilayer (section 3.2.1). One of the characteristics of a supported lipid bilayer 
is that it retains its fluidity when on a solid support. Changes in this fluidity can easily 
be tested using FRAP. A fraction of fluorescently labelled lipids is incorporated into 
the SLB, and a small spot in the SLB is bleached by a high intensity light pulse. The 
fluidity in the bilayer causes the florescence in the spot to recover by the diffusion of 
non-bleached fluorescent lipids into the bleached area and vice versa. By analysing 
the recovery, the diffusion constant can be calculated. Here, calculations based on the 
Hankel transform was used, a method less sensitive to noise than tradition methods.87 
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5.4 Isoelectric	  point	  analysis	  
Analysis of surface charge is important in understanding the behaviour of materials 
used in diagnostics, implants and as cell culture substrates as it influences protein 
adsorption, complement activation and blood coagulation. As an indicator of surface 
charge, the ζ-potential is usually measured using streaming potential or streaming 
current.88 A common setup for these measurements is a channel consisting of two 
parallel plates made from the material to be analysed. When an electrolyte is present, 
a charged double layer occurs at the walls. As the electrolyte is pushed passed, a 
streaming current develops caused by displacements in the charged double layer. The 
net stream of ions can be measured directly by electrodes on each end of the channel 
and the ζ-potential can be calculated by eq. 10: 
 ! = !"!" ∙ !! ∙ !! ∙ !!                                                                                                                                                                                                                                       (10) 
 
where dI/dp is the slope of streaming current (I) versus the differential pressure across 
the sample (p), η is the viscosity of the solution, ε0 is the permittivity, ε is dielectric 
constants for the electrolyte, L and A the length and cross-section area of the channel 
respectively. The isoelectric point, i.e. the pH where the ζ-potential is zero, can be 
determined by measuring the ζ-potential during a pH titration. 
5.5 Contact	  angle	  goniometry	  
The surface energy is another important property of biologically used materials. 
Simply speaking, surface energy can be considered as the energy needed to create a 
surface from the bulk material, i.e. the by breaking of chemical bonds. An easy 
estimation of the surface energy is by measuring the wettability by contact angle 
goniometry.89 A liquid droplet, typically water, is placed on the surface and the 
spreading of the drop will indicate the wettability (hydrophilicity/ hydrophobicity) of 
the surface (Figure 14). For homogenous surfaces, the surface energy can be 
estimated by repeating this measurement for liquids with different surface tension and 
plotting the contact angle θ versus the liquid surface tension. The surface energy is 
then equal to the liquid surface tension when cos(θ) = 1. 
 
 
Figure 14. Contact angles for surfaces with different wettability; a) a super-hydrophilic surface 
with θ<10°, b) a hydrophilic surface with θ<90°, c) a hydrophobic surface with θ>90°. 
 
a) b) c)
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6 Summary	  of	  results	  
This section shortly explaisn the main experimental results, most of which are 
included in the appended papers. Since a variety of GAG derivatives, surface 
modifications and immobilization techniques have been used during this work, an 
overview of this will be presented in section 6.1. A more detailed description on the 
GAG platforms used, how they were developed and characterized is presented; 
looking both at the immobilization itself (6.2) as well as the effect of immobilization 
on subsequent interactions (6.3). Finally, an example of how the developed GAG 
platforms can be used to study more complex biological systems will be presented (0). 
6.1 Toolbox	  for	  immobilization	  of	  glycosaminoglycans	  
 
 
Figure 15. An overview of the GAGs used in this study; including modifications and 
immobilization. Thumbnails from this figure will be used throughout the results section to refer 
to the GAG and immobilization strategy used. 
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6.1.1 Surface	  modifications	  
As surface modifications for GAG immobilization, both SAMs and SLBs were used. 
 
Two kinds of SLBs (section 3.2.1) were used, either presenting carboxyl 
groups (SLB-COOH) or amines groups (SLB-NH2). The bilayers were 
formed by vesicle rupture on silica surfaces, characterized in QCM-D by frequency 
and dissipation shifts of Δf = ~ -26 Hz and ΔD < 0.5⋅10-6 respectively.23 Formations 
of these SLBs are summarized in Figure 16 and discussed in detail in paper I. 
 
 
Figure 16. QCM-D frequency and dissipation shift for formation of SLBs used in paper I. 
The development of a suitable biotinylated SAM (section 3.2.2) for 
QCM-D measurements has been described previously,90 and is also 
explained in paper II. This surface modification was used for QCM-D and SPR 
measurements. In all cases, the SAMs were prepared ex-situ and binding of SA was 
performed in-situ (Figure 8). 
 	  
 25 
6.1.2 Glycosaminoglycans	  
 The GAGs used in this study were supplied from INNOVENT (Jena, 
Germany), a collaborating partner within the project FIND & BIND. To allow for 
directed immobilization, the GAGs were functionalized with hydrazid or biotin in a 
side-on or an end-on configuration. HA is a non-sulfated GAG, whereas CS is 
sulfated. In order to study the effect of sulfation, HA was sulfated. HA with varying 
degrees of sulfation would be beneficial for many protein interaction studies. Also CS 
was extra sulfated. The degree of functionalization and sulfation is expressed in terms 
degree of substitution (DS) of possible sites on each repeating unit, i.e. each 
disaccharide. For example, introduced hydrazid groups are coupled to carboxyl 
groups on the chain (Figure 9). Each HA repeating unit has one carboxyl group, 
hence DShydr.=1 means that each repeating unit is tagged with one biotin, DShydr.=0.5 
means every second repeating unit and so on. Introduced sulfate groups are coupled to 
hydroxyl groups on the GAG chains and the same reasoning applies regarding DSs. 
6.2 Design	  and	  characterization	  of	  GAG-­‐platforms	  
The immobilizing strategies outlined above results in different structural properties of 
the immobilized GAGs. Some characteristics of the GAGs only become visible when 
studying GAG-related interactions and will be discussed in section 6.3. 
6.2.1 Side-­‐on	  immobilization	  of	  chondroitin	  sulfate	  
In paper 1, we wanted to take advantage of the benefits with using a SLB (section 
3.2.1) for immobilization of CS. Two different approaches were used, that both 
resulted in side-on immobilized CS. In the first strategy, hydrazide functionalized CS 
(h-CS) was let to react with EDC/NHS-activated carboxyl groups on the (SLB-
COOH), creating amide bonds (section 3.1.1). In the other strategy, the naturally 
occurring carboxyl groups on non-functionalized CS were instead activated and let to 
react with amine groups on a SLB (SLB-NH2), also resulting in amide bonds. The 
immobilization was followed in real time by QCM-D (Figure 17). 
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Figure 17. QCM-D frequency and dissipation shifts obtained when immobilizing CS side-on to 
SLBs. Left side: h-CS (DShydr. 0.2) added to activated (solid line) and non-activated (dashed 
line) SLB-COOH 5%. Right side: stepwise addition of bulk activated CS to SLB-NH2 5% 
(dashed line) and to SLB-NH2 55% (solid line). 
The high charge of CS, together with possible chain stiffness caused difficulties in 
reaching high amounts of immobilized material. Buffer conditions, as well as 
functionalization degree and functional lipid ratio needed to be optimized. 
Immobilized amount of functionalized CS were approx. 25 ng/cm2 using the 
Sauerbrey equation (eq. 6). This is reasonable for a thin CS layer immobilized 
predominantly in a side-on configuration. It was easier to increase the amount of 
immobilized CS on the amine bilayer (55 ng/cm2), likely due to the increased amount 
of amine groups exerting an attractive force on the negative CS. The immobilizing 
method did not seem to affect the viscoelastic properties of the layers. 
 
SLBs have a dynamic structure, which is often a benefit. However, this can pose 
problems when immobilizing long chains or large structures as lipid material could 
potentially be removed.91 Thus for comparison, h-CS was immobilized to SAM-
COOH. Only small differences were seen when comparing the immobilized amount 
of CS to the SAM (Δf = 2.3 ± 0.5 Hz, ΔD = 0.4 ± 0.01⋅10-6), and the SLB (Δf = 1.5 ± 
0.4 Hz, ΔD = 0.6 ± 0.3⋅10-6), suggesting that the fraction of DOPE-COOH lipids is a 
rather good measure of the number of carboxyl groups exposed at the surface and that 
the low response is not caused by removal of lipid material. 
 
The lateral diffusion of lipids in the SLB was also assessed in fluorescence recovery 
after photobleaching (FRAP) experiments. The diffusion coefficient (D) of 
fluorescently labeled lipids was calculated, showing no significant difference between 
a functional bilayer and bilayer with immobilized CS, showing that the lipid 
molecules in the SLB retained their lateral mobility. 
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Figure 18. FRAP images of SLB-NH2 1% of fluorescently labelled lipid (NBD-POPC) without 
(left) and with (right) immobilized CS. After bleaching, 30 images were taken with a 5 s pause 
in between. The last image is shown to the right in each section. 
6.2.2 End-­‐on	  immobilization	  of	  glycosaminoglycans	  
 
 
An alternative immobilization configuration to 
side-on, is pinning the GAG end-on to the 
surface, similarly to how a GAG is attached to 
its protein core in a proteoglycan (Section 2.1 and 3.3). Here, the reducing end was 
used to attach a functional molecule at only one end of the GAG (Figure 9). As a 
continuation on the side-on immobilization strategy used above, CS was end-on 
functionalized with a hydrazide molecule. However, this did not lead to any 
detectable immobilized amounts on a SLB. Instead a biotin group was attached to the 
end and the GAG was immobilized to a SAM using the strong interaction between 
biotin and streptavidin (section 3.1.2). This strategy was evaluated in paper II.  
 
Figure 19 shows immobilization of end-on biotinylated chondroitin sulfate (b-CS), 
hyaluronic acid (b-HA) and sulfated hyaluronic acid (b-sHA) to a monolayer of SA 
on a SAM, monitored with QCM-D.  
 
 
Figure 19. QCM-D graph showing immobilization of b-HA (dashed line), b-sHA (solid line) 
and b-CS (dotted line) to SA on a SAM, and subsequent rinsing. 
D = 0.87 ± 0.2 µm2/s D = 0.95 ± 0.1 µm2/s 
10
-0
-10
-20
-30
-40
Fr
eq
ue
nc
y 7
 [H
z]
Time [min]
6
5
4
3
2
1
0
-1
Time [min]
Di
ss
ip
at
io
n 7
 (1
0-
6 )
0      1       2       3      4       5       6      7       8                  0      1       2       3      4       5       6      7       8                  
BB B
 28 
There is a difference in molecular weight between the used GAG derivatives (Table 
1). However, the immobilized amounts seen with QCM-D do not scale with the 
difference in molecular weight. The hydration of GAGs is important in many tissues 
like cornea to give opacity, skin to give viscoelasticity, and cartilage to give damping 
(cartilage consists of about 75% water). To investigate whether the difference in 
immobilized amount in fact comes from a difference in layer water content, the same 
measurements were made using SPR (Figure 20). The amount of associated water 
can be estimated by subtracting the mass measured with SPR from that measured with 
QCM-D (section 5.2).76,85 
 
 
Figure 20. SPR sensorgram showing immobilization of b-HA (dashed line), b-sHA (solid line) 
and b-CS (dotted line) to SA on a SAM with subsequent rinsing.  
In order to reach saturation of b-CS multiple injections were needed (not shown). The 
immobilized mass monitored by QCM-D (GAG + associated water), was estimated 
using the Voigt model. To estimate the mass of immobilized GAGs in SPR, eq. 9 
(section 5.2) was used with β = 0.9 to account for a distance of 5-10 nm from the 
sensing surface caused by the immobilization layer (SAM + SA).28 This, along with 
the estimated water content is summarized in Table 1.  
 
Table 1. Physical and optical properties of the GAGs along with measured masses and 
estimated water content of end-on immobilized GAGs. 
 Mw [Da] 
dn/dc 
[ml/g] 
CSPR 
[ng/cm2] 
mQCM-D 
[ng/cm2] 
mSPR 
[ng/cm2] 
water 
content 
[%] 
b-CS 20k 0.147 0.081 110 11.2 ± 1.7 90 
b-HA 23k 0.160 0.074 1080 19.8 ± 1.1 98 
b-sHA 30k 0.147 0.081 230 20.8 ± 1.6 91 
 
The degree of hydration estimated for CS and sHA is roughly the same, although their 
sulfation differ by a factor of 3 (DSS(sHA) > DSS(CS)). The great difference between 
HA and sHA seen in QCM-D is likely due to a higher water content (98% versus 
91%) based on these results. However, the molecular weight for sHA is higher which 
should result in a greater immobilized mass assuming the same grafting density. That 
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this is not the case and that the immobilized mass for CS is so low can be due to 
strong electrostatic repulsion between the sulfate groups and conformationally more 
constrained polymer chains. Increasing the ionic strength did not solve this issue.  
 
To further characterize the GAG layers, ζ potential measurements and contact 
angle measurements were made. Results are summarized in Figure 21. 
 
 
Figure 21. Measurements of a) ζ potential dependence on pH and b) water contact angles for 
surfaces displaying SA only, and SA with end-on immobilized GAGs. Solid line: SA, dashed 
line: b-HA, dotted line: b-sHA.  
For both measurements, there was a clear effect on surface characteristics upon 
immobilization of GAGs. The difference between the GAG variants was however not 
significant. The most striking difference between the derivatives lies in their sulfation. 
For ζ potential, the occurrence of sulfate groups is expected to lower the isoelectric 
point due to a higher charge of the polymer. The influence of sulfate groups in the 
wettability is less straightforward as both hydroxyl groups and sulfate groups are 
expected to yield a very hydrophilic polymer. It is important to notice that both the 
QCM-D and SPR results point to a difference in surface coverage, potentially also 
influencing the results seen here. There could therefore be an effect from the 
underlying SA layer, increasing the isoelectric point and the contact angle. Using 
longer GAG chains could reduce this effect and potentially show a greater difference 
between the derivatives. 
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6.3 Bio-­‐functional	  evaluation	  of	  GAG-­‐platforms	  
6.3.1 CS	  &	  type	  I	  collagen	  à 	  Polyelectrolyte	  behaviour	  
To illustrate the polyelectrolyte nature of GAG-protein interactions, the interaction 
between CS and type I collagen was studied (Section 4.2, Figure 22). 
 
 
Figure 22. QCM-D frequency and dissipation signals for addition of type I collagen in high 
(marked with squares) and low (without marks) ionic strength buffer to deactivated SLB-
COOH 5% (dashed curves) and to SLB-COOH with immobilized h-CS (DShydr. 0.2) (solid 
curves). Brackets indicate differences between sample and control for high and low ionic 
strength, respectively. (Gaps in curves are introduced to align the rinsing events; no 
information was added or removed.) 
As expected for a polyelectrolyte interaction, it is highly dependant on ionic strength 
and pH;92 at pH 7 there was very little binding of type I collagen to CS (not shown) 
whereas at pH 5 there was a remaining binding between type I collagen and CS after 
rinsing in high ionic strength buffer. More binding was seen when collagen was added 
in low ionic strength buffer compared to a high ionic strength one. This experiment 
also shows the suitability of using the SLB as an immobilization background; very 
little collagen bound non-specifically when CS was not present. Collagen is often 
used as a positively charged linker when building layer-by layer assemblies consisting 
of GAGs (section 3.1.3).93 
6.3.2 CS	  &	  BMP-­‐2	  à 	  A	  growth	  factor	  reservoir	  
The interactions between GAGs and growth factors are interesting to study because of 
the importance in tissues and the potential of using a combination of GAGs and 
growth factors in therapeutics. CS has recently gained increased interest because of its 
role in bone and cartilage tissue and its interactions with different growth factors. The 
growth factor bone morphogenetic protein-2 (BMP-2) is frequently used in research, 
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primarily with the aim of stimulating bone growth and regeneration.59 The interaction 
between these two molecules was studied (Figure 23) and presented in paper I. 
 
 
Figure 23. QCM-D frequency and dissipation signals when adding BMP-2 to h-CS 
immobilized to SLB-COOH 5% (left) and CS immobilized to SLB-NH2 20% (right) (solid lines). 
Addition was made in both low (top) and high (bottom) ionic strength acetate buffer. Control 
measurement, in absence of CS, is marked with dashed lines. After addition, the system was 
rinsed with the acetate buffer just used (indicated in the graph), and later with PBS (not 
shown). 
Although the dimer BMP-2 is a quite small molecule (26 kDa) and there are low 
amounts of CS immobilized on the surface, the binding induces large responses. 
Using both low and high ionic strength buffer distinguishes between non-specific and 
specific interaction; in low ionic strength buffer there is no difference between BMP-2 
binding to CS or to the negatively charged background of SLB-COOH, increasing the 
ionic strength displays a lower but presumably specific interaction. When using the 
positively charged background SLB-NH2, there is no unspecific interaction as the 
positively charged BMP-2 is rather repelled. The large amounts of BMP-2 that bound 
to CS immobilized on SLB-NH2 compared to on SLB-COOH at high ionic strength 
can in part be due to the added mass of CS when using this strategy. Also, CS is here 
expected to be more in its native form, as it has not been functionalized with 
hydrazide. Structural rearrangements are likely to occur as CS and BMP-2 interact, as 
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the reaction did not reach equilibrium during the used conditions. The appearance 
could also be due to an aggregation of BMP-2 induced at the sensor surface. A cross-
linking behavior between GAGs and proteins has been shown for other systems, like 
HA and the dimer TSG-6.47 Two binding sites for the GAG heparin have been 
suggested63 and a similar interaction with CS could therefore be likely. Whether this 
interaction is of a cross-linking nature or if the CS chain can accommodate itself in a 
binding pocket of BMP-266 is too early to say. However, this study illustrates the 
crucial role of GAG immobilization in elucidating more complex interaction 
mechanisms.  Also, as BMP-2 is not dissociating from CS upon rinsing, the system 
could potentially be used as a growth factor-presenting cell culture substrate. 
6.3.3 HA	  &	  aggrecan	  à 	  Building	  the	  ECM	  structure	  
To study the interaction between HA and aggrecan, HA was immobilized in several 
ways and the interaction was studied with QCM-D (Figure 24, Table 2), presented in 
paper II. 
 
 
Figure 24. Aggrecan binding to surface immobilized HA in three different ways; end-on 
biotinylation (full and half coverage), side-on biotinylation, and side on without introduced 
functional groups. 
Table 2. Binding of aggrecan to HA derivatives immobilized according to different strategies. 
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Because the amount of surface-bound HA depended on the immobilization method, 
aggregan binding was normalized to the mass of the HA layer underneath. Bound 
masses were estimated using the Sauerbrey equation. In view of the viscoelastic 
nature of the adlayer, these values do most likely not reflect accurate absolute values. 
They do however allow for a valid comparison between the different samples. When 
studying GAG-protein interactions, the end-on configuration is often considered to be 
the most natural since it resembles the structure of a proteoglycan. However, HA is 
not found in this configuration, but is free in the ECM. In line with this and the likely 
orientation of the HA-aggrecan interaction (Figure 3a), side-on immobilization of 
non-functionalized HA gives the highest interaction with aggrecan. For side-on 
immobilization of biotinylated HA, there is most likely too many biotin groups 
present on the molecule to enable an interaction. For end-on immobilization, there is 
likely sterical hindrance for the highly hydrated aggrecan molecules to reach the side 
of the HA chains, supported by that decreasing the surface coverage increases the 
interaction. To better estimate the actual masses bound, comparison with SPR 
measurements is in progress. 
6.3.4 HA	  &	  hyaluronidase	  	  à 	  Probing	  biofunctionality	  	  
From the results presented above, it is clear that the immobilizing strategy strongly 
affects GAG-protein interactions. Many ECM components reacting with GAGs are 
either not commercially available or often expensive. There is hence a need for 
cheaper evaluation of GAG immobilization. In paper II, the enzyme hyaluronidase 
(HAase, section 4.2) was investigated for its potential as a cheap evaluation protein. 
HAase randomly cleaves the β-1,4-glycosidic bond in HA under acidic conditions, 
yielding tetra-or hexasaccharide products.94-96 HA with different degrees of 
biontinylation were immobilized on a SAM and degradation caused by HAase was 
studied in QCM-D, seen as loss of mass. Degradation using HAase also highlight the 
effect of high biotinylation as side-on biotinylated HA was not degraded, hence not 
recognized as HA. End-on biotinylated HA was almost fully degraded, hence not 
experiencing the sterical hindrance to the same extent as aggrecan. Full degradation 
could potentially be reached by reducing the surface coverage. Bulk degradation by 
HAase using HPLC showed that the differences are in fact due to functionalization 
rather than surface immobilization. 
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6.4 Applications	  of	  the	  GAG	  platform	  
6.4.1 Virus	  infection	  via	  GAG	  attachment	  
Many enveloped viruses use glycoproteins on their membrane for initial attachment to 
a host cell. Attachment is vital for entry into the cell and replication of the viral 
genome, enabling spreading of the virus. Anti-viral drugs can hinder the viral 
infection either by targeting the attachment mechanism of the viral particle or its 
replication inside the host cell. Studying virus strains resistant to these drugs is 
important for developing new and better drugs, as well as for learning more about the 
infectious mechanism of a specific virus.  
 
Here, glycoproteins type C (gC) was isolated from the envelope of herpes simplex 
virus-1 (HSV-1). A wild-type strain, KOSc, was used as well as an anti-viral drug 
resistant strain, AC1. gC from KOSc has a mucin-like region in its N-terminal that is 
thought to bind to sulfated GAGs at the host cell membrane. gC from AC1 has a 
deletion in this mucin-like region and is because of this therefore expected to have an 
altered interaction with GAGs on the host cell.68,97 
 
gC from KOSc and AC1 was added at different concentrations to GAG-presenting 
surfaces and the binding was studied using SPR. Equilibrium responses as a function 
of protein concentration are plotted in Figure 25, I) as dependent of immobilized 
GAG and in II as depending on gC. For further experimental details, see appendix A. 
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Figure 25. I) Binding of gCs from HSV-1 strain KOSc (empty circles) and from AC1 (filled 
circles) to surface immobilized sHA, CS and HA. II) Binding of gCs from HSV-1 strain KOSc 
and AC1 to surface immobilized sHA (solid line), CS (dotted line), and HA (dashed line). 
(Bally, M., Altgärde, N., Trybala, E., Svedhem, S., Höök, F., Bergstöm, T., in progress) 
To compare the binding, the dissociation constant KD was estimated by K0.5 (grey, 
dotted line in Figure 25 II) (see section 4.1.3). It was found to be approx. 5 nM for 
binding of gC from KOSc and 70 nM for the binding of gC from AC1 to sHA and CS. 
The low binding of gC to non-sulfated HA, which was expected, made estimations of 
K0.5 difficult. There was no apparent difference in the binding affinity between sHA 
and CS for the gCs, but the saturation values differ greatly. There is lower amounts of 
CS on the surface, about 2/3 of the response value for sHA, which is roughly the 
difference in saturation seen for the gC from AC1. The difference in saturation values 
seen for gC from KOSc are greater than that, about 2/6. The sulfation on sHA is 
synthetically derived, and about 3 times higher than the natural sulfation occurring on 
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CS. This difference between the GAG derivatives seems to be sensed more by gC 
from the wild-typ strain KOSc than by gC from the mutant strain AC1. 
 
A higher affinity between sulfated GAGs and gC from KOSc is apparent. 
Furthermore, the amount of material binding of the mutated gC from AC1 is much 
greater. The difference in Rmax, also associated with a slower dissociation rate (Figure 
26), could suggest an aggregation of this gC. Both gCs include a hydrophobic 
transmembrane region that could induce micelle formation. Also, since gC from AC1 
lacks the mucin-like region likely repulsing other nearby gCs, micelle formation could 
be more pronounced for gC from AC1. 
 
 
Figure 26. Dissociation from surface immobilized sHA of gC from a) KOSc and b) AC1 at a 
gC concentration of 44.6 nM. (Bally, M., Altgärde, N., Trybala, E., Svedhem, S., Höök, F., 
Bergstöm, T., in progress) 
The above results can be linked to cell-infecting experiments for the two HSV-strains. 
Although lacking the mucin-like region, AC1 still binds to and infects cells. However, 
they do not release as well from the cell surface (Bergström et. al., unpublished 
results). Release will affect both entry and exit fro the virus particle; as to strong 
binding hinders the viron from going into the cell and could stop newly formed 
viruses on their way out from the cell. This is coherent with what is seen here, the gC 
from AC1 binds in high amounts but is not released. The mucin-like region does not 
seem to be a requisite for GAG-binding, but it rather has a crucial modulating ability, 
allowing the virus particles to also be released from the cell surface. 
 
K0.5 is only a true estimation of KD if the Langmuir equation holds, e.g. when there is 
no cooperativity in the binding (see section 4.1.3). In view of the shape of the curves 
in Figure 25, cooperativity is likely at least for the gC From AC1. Cooperativity can 
be estimated by fitting to extensions of the Langmuir equation, e.g. the Hill equation98 
or investigating the derivative of the binding curve. Analysis of this is on-going. 
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7 Looking	  back	  and	  looking	  ahead	  
The overall aim of my work is to investigate the function of glycosaminoglycans 
(GAGs) in bone and cartilage tissue, in term of how they interact with proteins, 
glycoproteins and cells. In order to do this in a controlled way, we wanted to 
immobilize the glycosaminoglycans to a surface. This proved to be a project on its 
own. 
What technique should be used? And what surface? How does immobilization affect 
subsequent interactions? How does orientation of the GAGs affect subsequent 
orientation? How do one quantify interactions between GAGs and proteins? 
 
In paper I, these issues were discussed for immobilization of chondroitin sulfate to 
supported lipid bilayers via amine coupling. There are clear benefits of using the lipid 
bilayers as an immobilizing layer because of the low unspecific interaction. In the 
paper, the influence of functional groups was investigated. In order to accomplish 
end-on immobilization instead of side-on, another immobilization strategy was 
evaluated in paper II, namely biotin-streptavidin immobilization on a self-assembled 
monolayer. This was evaluated in paper II. Throughout the project, interactions with 
various proteins have been investigated. These studies were very helpful in 
determining important aspects of the underlying GAG layer. For example, binding of 
aggrecan and hyaluronidase to immobilized GAGs (paper II) shows the effect of both 
functionalization and orientation where different aspects are important for different 
proteins. The end-on immobilized GAGs were successfully used to study binding 
mechanisms of virus glycoproteins. A setup like this provides valuable 
complementary results to conventional virus research. 
 
An interesting field in GAG research is the combination with growth factors, aiming 
towards cell experiments. In paper I, the high binding of the growth factor bone 
morphogenetic protein-2 to chondroitin sulfate was shown. These studies will be 
continued using end-on immobilized GAGs and investigating the effect of sulfation. 
This will also be beneficial in a study together with Prof. Anders Lindahl at the 
department of clinical chemistry and transfusion medicine, Sahlgrenska University 
Hospital, for studying the initial attachment of chondrocytes. The use of a cross-
linked hyaluronic acid scaffold has shown promising results for clinical 
applications,99 and the initial chondrocyte attachment to hyaluronic acid and other 
GAGs is interesting for improved scaffold design. 
 
Another possible application area for the GAG-platforms developed during this work 
is to study platelet (thrombocyte) activation studies, which can provide fundamental 
information on blood coagulation and related diseases. Currently used techniques for 
the quantification of platelet aggregation are based on light aggregometry, electrical 
impedance aggregometry or thromboelastometry, all performed under static or quasi-
dynamic conditions. In order to mimic the conditions found in human cardiovascular 
system it is important to perform studies under flow conditions and on surfaces 
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mimicking biological surfaces, e.g. lipid membranes or ECM components. Combining 
QCM-D with light microscopy could give valuable information for such a system, 
studying the effect of different surface coating on platelet activation and coagulation. 
This setup was used to study platelet adhesion on end-on immobilized hyaluronic acid. 
Hyaluronic acid has been suggested as a coating for stents to prevent stent-induced 
blood cloths.17 Essentially no binding of platelets to HA was seen using the suggested 
setup (Figure 27). 
 
Figure 27. Addition of platelet rich plasma to hyaluronic acid immobilized end-on on 
streptavidin modified self assembled monolayer. (Kunze, A., Altgärde, N., Hesse, C., 
Svedhem, S., in progress) 
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10 Appendix	  A	  
Experimental section for GAG-Virus protein interaction 
 
Herpes simplex virus-1 glycoproteins. Plaque purified wild-type strain of herpes 
simplex virus-1 (HSV-1), KOSc, was subjected to ten passages in african green 
monkey kidney (GMK AH1) cells in the presence of PI-88, a sulfated polysaccharide 
known to inhibit HSV attachment to cells.68,97 Glycoproteins for wild-type HSV-1 and 
escape variants were isolated. AC1, a HSV-1 strain that survived PI-88 was found to 
have deletion of 83 aa in the N-terminal region on glycoproteins gC. The deleted 
region lies in a mucin-like region of the gC hypothesized to be involved in the 
attachment of HSV-1 to cells. gC from KOSc and AC1 were aliquoted and frozen, 
and dissolved in PBS before measurements. 
 
Studying HSV glycoprotein-GAG interactions. KOSc and AC1 were dissolved in 
PBS and added at different concentrations to surfaces presenting end-on biotinylated-
CS, b-HA, and b-sHA. A flow of 5 ul/min was used for equilibrium measurements, 60 
ul/min for kinetic measurements. 
 
